| View |
|
DRP-14035-01
|
Telmisartan + Amlodipine (as besilate)
|
Mistralix
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARBs)/Calcium Channel Blocker
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
12 August 2024
|
07 June 2028
|
| View |
|
DRP-14286-02
|
Levodropropizine
|
Duro-Tuss LV
|
30 mg / 5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 August 2024
|
11 August 2028
|
| View |
|
DRP-14532-03
|
Febuxostat
|
Atenugen
|
40 mg
|
Film-Coated Tablet
|
Anti-gout (Preparation Inhibiting Uric Acid Production)
|
Innova Captab Limited
|
India
|
CLIDP Conversion
|
11 August 2024
|
03 October 2028
|
| View |
|
DRP-14658-02
|
Aripiprazole
|
Stabel-10
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Nobel ?laç Sanayii ve Ticaret A.?.
|
Turkey
|
CLIDP Conversion
|
12 August 2024
|
17 November 2028
|
| View |
|
DRP-15054-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Firbactam-1.5
|
1g/ 500mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin-Beta-lactamase Inhibitor Combination)
|
Med Biopharm Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 August 2024
|
04 August 2028
|
| View |
|
DRP-15093-03
|
Rosuvastatin (as Calcium)
|
None
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 August 2024
|
23 April 2029
|
| View |
|
DRP-15118-01
|
Olanzapine
|
Olzantic
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
11 August 2024
|
08 May 2029
|
| View |
|
DRP-13364
|
Diphenhydramine Hydrochloride
|
Hyphen
|
50 mg/mL
|
Solution for Injection (IM/IV)
|
H1-Receptor Antagonist (Antihistamine)
|
GRAND PHARMACEUTICAL (CHINA) CO., LTD.
|
China
|
-
|
26 September 2023
|
16 October 2028
|
| View |
|
DRHR-2371
|
Ethyl Alcohol
|
Family
|
70 mL per 100 mL (70% v/v)
|
Solution (Baby Oil Scent)
|
Antiseptic / Disinfectant
|
Pagoda Philippines, Inc.
|
Philippines
|
Initial [HR]
|
01 August 2024
|
01 August 2029
|
| View |
|
DRHR-2372
|
Isopropyl Alcohol
|
Family
|
70 mL per 100 mL (70% v/v)
|
Solution (Jasmine Scent)
|
Antiseptic - Disinfectant
|
Pagoda Philippines, Inc.
|
Philippines
|
Initial [HR]
|
01 August 2024
|
01 August 2029
|
| View |
|
DRHR-2373
|
Isopropyl Alcohol
|
Family
|
70 mL per 100 mL (70% v/v)
|
Solution (Jasmine Scent)
|
Antiseptic/Disinfectant
|
Pagoda Philippines, Inc.
|
Philippines
|
Initial
|
01 August 2024
|
01 August 2029
|
| View |
|
DRHR-2374
|
Isopropyl Alcohol
|
Family
|
70 mL per 100 mL (70% v/v)
|
Solution (Baby Oil Scent)
|
Antiseptic/Disinfectant
|
Pagoda Philippines, Inc.
|
Philippines
|
Initial [HR]
|
01 August 2024
|
01 August 2029
|
| View |
|
DR-XY49155
|
Levetiracetam
|
Ceaser 1000
|
1 g
|
Film-Coated Tablet
|
Antiepileptic
|
Pharmathen SA
|
Greece
|
Initial (Re-Application)
|
01 August 2024
|
01 August 2029
|
| View |
|
DR-XY49156
|
Levetiracetam
|
Exppra 500
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Exemed Pharmaceuticals
|
India
|
Initial (Re-Application)
|
01 August 2024
|
01 August 2029
|
| View |
|
DRP-15527
|
Betamethasone (as dipropionate) + Clotrimazole
Gentamicin (as sulfate).
|
Triodex
|
500 mcg/10 mg/1 mg (0.05%/1%/0.1%) per gram
|
Cream
|
Corticosteroid, Combination with antibiotics
|
S Kant Healthcare Ltd.
|
India
|
Initial
|
01 August 2024
|
18 November 2026
|
| View |
|
DRP-15529
|
Amphotericin B
|
Ampothin-Lip 50
|
5 mg/mL (50 mg/10 mL)
|
Suspension for Injection (I.V.)
|
Antifungal for Systemic Use
|
United Biotech (P) Limited.
|
India
|
Initial
|
01 August 2024
|
01 August 2029
|
| View |
|
DRP-15535
|
Febuxostat
|
Xuric 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Globela Pharma Private Limited.
|
India
|
Initial
|
31 July 2024
|
01 August 2029
|
| View |
|
DR-XY49143
|
Betamethasone Dipropionate
|
Betaroid
|
500 mcg/g (0.05% w/w)
|
Cream
|
Corticosteroid
|
Yash Medicare Pvt. Ltd.
|
India
|
Initial
|
01 August 2024
|
31 July 2029
|
| View |
|
DRP-15551
|
Ceftriaxone (as sodium)
|
Triamax
|
1 g
|
Powder for Injection
|
Antibacterial (Third-generation cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
31 July 2024
|
01 August 2029
|
| View |
|
DRP-15553
|
Cefotaxime (as sodium)
|
Protaxim 500.
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-generation cephalosporin)
|
Sance Laboratories Pvt. Ltd
|
India
|
Initial
|
31 July 2024
|
31 July 2029
|